A UF Health oncologist answers the most common questions about cell therapy, from who qualifies to how it differs from ...

Amanda Smith, registered nurse, of Huntsman Cancer Institute, helped lead novel research on MPN drug safety during pregnancy, ...

Nicholas Hornstein, MD, PhD discusses ctDNA in colorectal cancer, the INTERCEPT-TT trial, building Northwell's GI oncology program, and what better drugs will look like.

A 26-year story of survival: Overcoming myelofibrosis, finding a match for a bone marrow transplant, and enduring severe GVHD to help others. A retired teacher’s plans for "Act II" are derailed by a ...

The segment explores concepts of living well with cancer, advocacy, and community building for young patients facing long-term therapy. Dr. Florez notes that current reality for many young patients ...

CAR-T therapy achieved apparent complete remission in third-relapse mantle cell lymphoma, reinforcing “milestone” rituals like bell-ringing while underscoring the nonlinearity of survivorship ...

He thought CAR-T therapy marked the end of cancer. Months later, another diagnosis revealed the power of faith, hope and resilience.

Diagnosed with Hodgkin lymphoma at 18, Steve Garraty shares how survivorship, gratitude and purpose emerged from life's hardest chapter.

Incidental renal lesion workup resulted in an MRI read as indeterminate, prompting imaging surveillance rather than immediate intervention, with a six-month follow-up to assess stability. Emotional ...

Trodelvy dosing is 10 mg/kg IV on days 1 and 8 of 21-day cycles, continued until progression or unacceptable toxicity; pembrolizumab schedules follow prescriber determination. Safety requires ...

Susan Yaguda didn't set out to be extraordinary. She just kept saying yes. As a registered nurse and nurse manager at Atrium Health Levine Cancer Institute in Charlotte, North Car ...

Maintenance indication applies after response or stable disease following initial chemotherapy plus trastuzumab, with or without pertuzumab, in HR-positive, HER2-positive advanced breast cancer.